Chinese Guidelines for diagnosis and treatment of BCG adverse reactions

Title: Chinese Guidelines for diagnosis and treatment of BCG adverse reactions
Edition: Original
Classification: Standard guideline
Field: Comprehensive guideline
Countries and regions: China
Guidelines users: Paediatrics, infectious diseases, tuberculosis, urology, oncology and transplantation doctors, public health workers and related nursing staff.
Evidence classification method: GRADE
Development unit: Tuberculosis Branch of Chinese Medical Association, School and children tuberculosis branch of China Tuberculosis Prevention Association, Shenzhen Third people’s hospital
Registration time: 2022-03-08
Registration number: IPGRP-2022CN116
Purpose of the guideline: Adverse reactions occur from time to time after BCG inoculation and perfusion, but the clinical management of BCG adverse reactions has not been standardized at present, so this guide is formulated to guide medical staff to standardize and reasonably manage BCG adverse reactions.